Logo Logo
Switch Language to German

Pfirrmann, M.; Hasford, J.; Saussele, S.; Baerlocher, G. M.; Krause, S.; Hochhaus, A.; Hehlmann, R. and Lauseker, M. (2016): Comparison of survival between patients with and without switch to second-line tyrosine kinase inhibitor in a trial on chronic myeloid leukaemia with randomisation to first-line imatinib. In: Oncology Research and Treatment, Vol. 39: p. 221

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item